Corteva is rated a Buy with a 12.7% upside to a $80 target, driven by strong market leadership and operational efficiency. CTVA's dual-segment strategy and innovation in seeds and crop protection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results